Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000184343 | SCV000236968 | pathogenic | not provided | 2016-10-24 | criteria provided, single submitter | clinical testing | Although the c.77793_77794delTCinsA pathogenic variant in the TTN gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon Proline 25933, changing it to a Glutamine, and creating a premature stop codon at position 6 of the new reading frame, denoted p.Pro25933GlnfsX6. This pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. While other truncating TTN variants have been reported in approximately 3% of control alleles (Herman et al., 2012), c.77793_77794delTCinsA is located in the A-band region of titin, where the majority of truncating mutations associated with DCM have been reported (Herman et al., 2012). Additionally, the c.77793_77794delTCinsA variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, nor was it observed in the Exome Aggregation Consortium (ExAC) data set, indicating it is not a common benign variant in these populations. In summary, c.77793_77794delTCinsA in the TTN gene is interpreted as a pathogenic variant. |